Blackstone Life Sciences appoints four senior advisors

Blackstone's health care business named four industry heavy-hitters as senior advisors. The appointments come less than a year after Blackstone Life Sciences closed what it described as the largest private fundraise to date in this sector.

The four appointees are:

• Dr. Olivier Brandicourt, former CEO of European pharma giants Sanofi and Bayer
• Dr. Omar Ishrak, former chairman and CEO of medical device maker . . .
  

  Continue Reading

  Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.

  Monthly

  $30

  A pay-as-you-go plan to get you started

  → Instantly unlock all new and archived articles

  → Daily, weekly and monthly e-mail newsletters

  → Access to the weekly AW Deal Watch by AW Research

  Join Now

  Annual

  $300

  Required for access to AW Research

  Get more for less - 20% discount over monthly

  → Everything in Monthly PLUS:

  → Access to articles and data from AW Research

  → AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators

  Join Now
  Read more about: BlackstoneLife Sciences